Skip to main content

Table 3 Echocardiography parameters

From: Echocardiographic parameters in COVID-19 patients and their association with ICU mortality: a prospective multicenter observational study

Echoparameters

N

All

Survived

n = 233

Non-survivor

n = 340

P-value

LV systolic function (Visual gestalt method)

540

    

Hyperdynamic

 

12 (2.22)

2 (0.94)

10 (3.05)

0.007

Good

341 (63.15)

142 (66.98)

199 (60.67)

Mildly reduced

47 (8.70)

21 (9.91)

26 (7.93)

Moderately reduced

93 (17.22)

39 (18.40)

54 (16.46)

Severely reduced

47 (8.70)

8 (3.77)

39 (11.89)

RWMA

506

90 (17.79)

24 (12.24)

66 (21.29)

0.010

LV diastolic function

E¥ (cm/sec)

215

79.43 (23.12)

83.51 (21.89)

76.60 (23.60)

0.030

A¥ (cm/sec)

202

75.83 (23.11)

71.02 (21.81)

79.18 (23.49)

0.013

E/A§

202

1.01 (0.78–1.30)

1.14 (0.94–1.42)

0.91 (0.70–1.14)

 < 0.001

e′ (cm/Sec)

208

10.27 (2.95)

10.84 (2.75)

9.88 (3.03)

0.021

E/e′§

207

8.09 (2.65)

8.05 (2.59)

8.11 (2.69)

0.872

LV dilatation

573

251 (43.80)

109 (46.78)

142 (41.76)

0.235

RV dilatation

358

61 (17.04)

21 (15)

40 (18.35)

0.411

TAPSE (cm)

26

2.2 (1.8–2.4)

2.3 (1.8–2.56)

2.12 (1.7–2.3)

0.263

Troponin § (ng/ml)

281

0.06 (0.01–0.40)

0.03 (0.01–0.24)

0.07 (0.02–0.51)

0.015

  1. Values are n (%), p value from Chi-square test of association. ¥Mean (SD), independent sample t-test was used for comparison. §Median (IQR), p value from Mann–Whitney U test, RWMA Regional wall motion abnormality, LV Left ventricle , RV Right ventricle, TAPSE Tricuspid annular plane systolic excursion